Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Explore ways to earn money while you sleep through smart investments and strategies. Let your money work for you!
27,944 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A trio of XRP ETFs began trading in 2026, offering exposure to XRP without direct coin ownership. This piece reviews ...
Medicare Part B costs are climbing in 2026, pulling more from Social Security checks and narrowing the real value of ...
In 2026, higher-income retirees still face IRMAA charges on Medicare Part D, even if their pension pays part premium....
Upwork stock has fallen this year as a big investor sold a multi-million stake, raising questions about the company’s...
In March 2026, traders are eyeing the best stocks under $5 as market volatility creates opportunities for disciplined...
SpaceX is preparing for a high-profile IPO, but history suggests a meaningful first-year decline could precede longer...
As markets navigated a cautious session, Sunrun’s new framework with Tesla and Renew Home pushed renewable energy equ...
Solventum wraps up 2025 with meaningful growth and a clearer path to profitability. This article breaks down the numb...
A Reuters briefing this week reignited the debate over Banksy’s anonymity and its effect on art values, prompting a r...
As investors scan headlines in June, Comcast's bold $8 billion UK theme park plan stands out. This article explains w...
Icon stock crushed Wednesday as the CRO leader posted a stronger quarter than expected. We break down what drove the ...